NCT05921461View on ClinicalTrials.gov

The Use of HOVR Technology for Assessment of Blood Associated Parameters

CompletedOBSERVATIONAL

Enrollment

60

Participants

Timeline

Start Date

May 1, 2022

Primary Completion Date

March 16, 2023

Study Completion Date

March 16, 2023

Conditions

Peripheral Arterial DiseaseDiabetes Mellitus

Trial Locations (1)

Unknown

Hadassah University Medical Center, Jerusalem

All Listed Sponsors

collaborator

Hadassah Medical Organization

OTHER

lead

Votis Subdermal Imaging Technologies LTD

INDUSTRY